For years, we treated ADHD as a personal issue. Something an employee dealt with on their own, outside the scope of workforce strategy. That view doesn't hold up anymore.

ADHD is one of the most common neurodevelopmental conditions among working-age adults, affecting an estimated 3 to 6 percent of the population. It's also significantly underdiagnosed and undertreated. For employers and plan sponsors, that gap shows up in places you're already paying attention to. Productivity. Retention. Disability. Mental health utilization. The cost is real.

If you're focused on workforce health and mental health, ADHD belongs in the conversation.

What goes unrecognized still gets paid for

Most adults with ADHD spend years navigating symptoms without a diagnosis. Trouble with attention, organization, prioritization, time management, and executive function gets read as a performance issue rather than a treatable health condition. So, ADHD shows up in your data. Just under another name.

Research from the World Health Organization links untreated ADHD to about 22 lost workdays per employee each year. Adults with unmanaged ADHD are significantly more likely to lose their jobs, change roles, and experience periods of unemployment. They earn less over their careers and report worse employment outcomes overall.

For your business, that lands as absenteeism, presenteeism, lower output, performance concerns, and turnover. For your benefits program, it lands as disability claims, mental health utilization, and rising healthcare costs.

ADHD also rarely travels alone. Anxiety, depression, burnout, sleep issues, and substance use frequently sit alongside it. In a lot of cases, you're funding treatment for the secondary condition while the underlying ADHD stays invisible. That's a costly cycle. Employees get support, but the root cause keeps generating new symptoms to treat.

Demand is rising. Fast.

The pressure to act is harder to ignore every quarter.

Across Canada, demand for ADHD-related care is climbing. Manulife reported a 24.5 percent increase in adult claimants for ADHD medications between 2021 and 2022. More recently, JAMA Network Open found that new stimulant prescriptions in Ontario jumped 157 percent between 2015 and 2023.

That's awareness moving faster than access can keep up.

Many of your employees are still facing long waits for assessment, a shortage of primary care providers, and out-of-pocket costs for private evaluations. Recognizing the symptoms is often the easiest step. Getting from "I think this might be me" to a real diagnosis, treatment plan, and ongoing follow-up is where the system tends to break down.

So here's the question worth sitting with. If more of your employees are looking for ADHD care, is your plan actually built to support them?

The blind spot in most benefits strategies

Historically, ADHD has gotten less airtime than other neurodevelopmental conditions in workplace health strategy.

Think of your current plan in terms of breadth, the range of entry points and conditions it covers. Psychological services, an EAP, broader mental health awareness work. This is where most organizations have done the most work, and it's the right place to start. But breadth alone doesn't fully cover what employees with ADHD need.

A lot of plans still concentrate on counselling, with limited support for assessment, diagnosis, medication management, and ongoing clinical follow-up. So an employee who suspects they have ADHD runs into a fragmented care path that makes it hard to move from recognition to treatment.

Stigma is the other layer. In our latest national research survey, Living with Complexity: Navigating Chronic Care in Canada found that more than one in five working Canadians have skipped disclosing a health condition at work because they expected negative consequences. Among Canadians living with ADHD, confidence in the healthcare system was the lowest of any group studied, and many said they felt dismissed during diagnosis.

When your employees don't feel safe asking for help, or can't access care when they do, your organization absorbs the cost on the back end.

What to ask before you build anything new

Here's the practical part. You don't need to build a brand-new program to start.

You can begin by asking whether ADHD is already shaping the outcomes you're trying to move.

Are your disability claims clustering around stress and burnout? Are productivity concerns concentrated in specific teams or populations? Are your employees stuck on long waits for a neurodevelopmental assessment? Does your current plan actually support diagnosis, treatment, and ongoing management, or just counselling sessions?

This is where depth matters. Mental health conditions like anxiety and depression sit on a continuum, and your employees' needs don't stop the moment they get through the door. 

A handful of counselling sessions can improve access, but access isn't the same as support. Real depth, like the approach we take to mental health at Maple, looks like assessment, coordinated treatment, and ongoing care that can keep up with complex needs over time. ADHD is one of the clearest places you'll see the gap between opening the door and helping someone navigate what's on the other side.

For plan sponsors, consultants and advisors, those questions move the conversation past traditional benefits design and into a more complete view of workforce health.

The organizations that are invested in the health of their employees  aren't treating ADHD as a niche medical condition. They're treating it as a workforce issue with measurable effects on performance, retention, disability, and employee experience.

Modern plan sponsors have a choice in front of them. They can keep treating ADHD as something employees are responsible for figuring out on their own. Or they can recognize it as an emerging part of workforce health strategy, and build a plan that meets the moment.

That's the gap Beyond ADHD, now part of Maple, was built to close. Members can move from suspecting they have ADHD to assessment, diagnosis, and ongoing care with nurse practitioners who focus exclusively on ADHD, in days rather than the year-plus waits common in the public system. For plan sponsors, it's a practical way to add depth to a benefits strategy that already has the breadth.